000 | 01176 a2200337 4500 | ||
---|---|---|---|
005 | 20250513192721.0 | ||
264 | 0 | _c19991004 | |
008 | 199910s 0 0 eng d | ||
022 | _a0025-729X | ||
024 | 7 |
_a10.5694/j.1326-5377.1999.tb123595.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShiell, A | |
245 | 0 | 0 |
_aHepatitis C: an economic evaluation of extended treatment with interferon. _h[electronic resource] |
260 |
_bThe Medical journal of Australia _cAug 1999 |
||
300 |
_a189-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntiviral Agents _xeconomics |
650 | 0 | 4 | _aAustralia |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aDecision Support Techniques |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xeconomics |
650 | 0 | 4 | _aMarkov Chains |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aQuality-Adjusted Life Years |
700 | 1 | _aBrown, S | |
700 | 1 | _aFarrell, G C | |
773 | 0 |
_tThe Medical journal of Australia _gvol. 171 _gno. 4 _gp. 189-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5694/j.1326-5377.1999.tb123595.x _zAvailable from publisher's website |
999 |
_c10451538 _d10451538 |